Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial

Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Two new publications were added to the Publications section of the study record. An existing citation was updated to reflect final bibliographic details (publication date and page range) for the prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial.
    Difference
    0.0%
    Check dated 2026-05-27T16:27:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new citation for a plain-language review of finerenone in heart failure with mildly reduced or preserved ejection fraction has been added, and the page revision was updated to v3.5.4.
    Difference
    0.0%
    Check dated 2026-05-20T09:25:14.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan District to Taoyuan city, clarifying the location as Taoyuan, Taiwan, 33305 for that study site.
    Difference
    0.0%
    Check dated 2026-05-06T02:19:22.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a minor update to the page’s platform. No study content or data is changed by this update.
    Difference
    0.0%
    Check dated 2026-04-28T21:39:36.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Updates include corrected spelling/formatting for two listed locations and a revised citation entry for a journal article. The page’s displayed site revision version is also updated.
    Difference
    0.0%
    Check dated 2026-04-21T15:55:19.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added two 2026 JAMA Cardiol. publications related to the FINEARTS-HF trial: EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial, and Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure.
    Difference
    0.0%
    Check dated 2026-04-06T03:56:56.000Z thumbnail image

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.